Synlogic, Inc. logo

Synlogic, Inc.

NASDAQ:SYBX

Overview | Financials
Company Name Synlogic, Inc.
Symbol SYBX
Currency USD
Price 1.45
Market Cap 16,959,345
Dividend Yield 0%
52-week-range 0.234 - 5.708
Industry Biotechnology
Sector Healthcare
CEO Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
Website https://www.synlogictx.com

An error occurred while fetching data.

About Synlogic, Inc.

Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat

Related Stocks

Enlivex Therapeutics Ltd. logo

Enlivex Therapeutics Ltd.

ENLV

1.27 USD

Homology Medicines, Inc. logo

Homology Medicines, Inc.

FIXX

0.935 USD

Eliem Therapeutics, Inc. logo

Eliem Therapeutics, Inc.

ELYM

7.39 USD

Clearside Biomedical, Inc. logo

Clearside Biomedical, Inc.

CLSD

0.97 USD

LENSAR, Inc. logo

LENSAR, Inc.

LNSR

4.53 USD

eFFECTOR Therapeutics, Inc. logo

eFFECTOR Therapeutics, Inc.

EFTR

0.04 USD

Longboard Pharmaceuticals, Inc. logo

Longboard Pharmaceuticals, Inc.

LBPH

34.86 USD

Financials

Numbers are in millions USD

Numbers are in millions USD